Page last updated: 2024-10-21

tramiprosate and Peripheral Nervous System Diseases

tramiprosate has been researched along with Peripheral Nervous System Diseases in 1 studies

tramiprosate: GABA receptor agonist and a glycosaminoglycan mimetic; has nootropic acitivity; structure; a sulfonate analog of GABA
3-aminopropanesulfonic acid : An amino sulfonic acid that is the 3-amino derivative of propanesulfonic acid.

Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fragai, M1
Comito, G1
Di Cesare Mannelli, L1
Gualdani, R1
Calderone, V1
Louka, A1
Richichi, B1
Francesconi, O1
Angeli, A1
Nocentini, A1
Gratteri, P1
Chiarugi, P1
Ghelardini, C1
Tadini-Buoninsegni, F1
Supuran, CT1
Nativi, C1

Other Studies

1 other study available for tramiprosate and Peripheral Nervous System Diseases

ArticleYear
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX).
    Journal of medicinal chemistry, 2017, 11-09, Volume: 60, Issue:21

    Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Drug

2017